Cefotaxime/sulbactam plus gentamicin as a potential carbapenem- and amikacin-sparing first-line combination for neonatal sepsis in high ESBL prevalence settings

por Readman, J B, Acman, M, Hamawandi, A, Chiu, Cheng-Hsun, Sharland, M, Lindsay, J A, Standing, J F
Publicado 2023